The HALP Score's Prognostic Value for the Elderly (≥75 years) Patients Following Percutaneous Coronary Intervention for Acute Myocardial Infarction-Uncorrected Proof
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · 2025 · 388-397
DOI: 10.5543/tkda.2025.45606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2025. Verfasst von Cemalettin Yılmaz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Yalova University School of Medicine, Yalova, Türkiye. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
OBJECTIVE: Despite the fact that percutaneous coronary intervention (PCI) lowers mortality following acute myocardial infarction (AMI), older patients (≥75 years) are still at high risk of mortality. The purpose of this study was to evaluate the prognostic significance of the HALP score, which reflects the inflammatory and nutritional status, in this population. METHOD: We retrospectively included 128 elderly patients who had PCI at our institution between 2019 and 2022. The primary endpoint of the study was long-term all-cause mortality. The study population was categorized into two distinct groups based on survival status: survivors and non-survivors. A multivariable Cox regression analysis was conducted to identify independent predictors of long-term all-cause mortality. RESULTS: The median follow-up time was 49.9 (35.6-62.74) months. In multivariable analysis, the HALP score and CRP independently predicted all-cause mortality at long-term follow-up (hazard ratio (HR): 0.96, 95% confidence interval (CI): 0.94-0.99, p=0.003; HR: 1.04, 95% CI: 1.01-1.07, p=0.020; respectively). Receiver operating characteristic curve analysis identified 26.252 as the optimal HALP score cut-off for predicting mortality (area under the curve (AUC): 0.764; 95% CI: 0.672-0.855; p< 0.001), with 73% sensitivity and 70.3% specificity. The HALP score demonstrated a higher AUC value, indicating better discriminative power compared to its individual components. In Kaplan-Meier analysis, patients with HALP score< 26.252 had a greater follow-up death (log rank p< 0.0001). CONCLUSION: The HALP score is an independent predictor of long-term all-cause death in older AMI patients following PCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Yalova University School of Medicine, Yalova, Türkiye.
- Department of Cardiology, Yalova State Hospital, Yalova, Türkiye.
- Department of Cardiology, Muş State Hospital, Muş, Türkiye.
- Department of Cardiology, Kartal Koşuyolu Training and Research Hospital, Kartal, Istanbul, Türkiye.
Zitieren
APA
Yılmaz, C., Üngan, İ., Arslan, E., Çitil, E., Uluuysal, Ö., Tiryaki, M. M., Şen, D., Karaduman, A., & Zehir, R. (2025). The HALP Score's Prognostic Value for the Elderly (≥75 years) Patients Following Percutaneous Coronary Intervention for Acute Myocardial Infarction-Uncorrected Proof. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 388-397. https://doi.org/10.5543/tkda.2025.45606
Vancouver
Yılmaz C, Üngan İ, Arslan E, Çitil E, Uluuysal Ö, Tiryaki MM, et al. The HALP Score's Prognostic Value for the Elderly (≥75 years) Patients Following Percutaneous Coronary Intervention for Acute Myocardial Infarction-Uncorrected Proof. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 2025:388-397. doi:10.5543/tkda.2025.45606
BibTeX
@article{Ylmaz2025,
author = {Yılmaz, Cemalettin and Üngan, İsmail and Arslan, Enes and Çitil, Emrah and Uluuysal, Ömer and Tiryaki, Muhammet Mücahit and Şen, Doğan and Karaduman, Ahmet and Zehir, Regayip},
title = {The HALP Score's Prognostic Value for the Elderly (≥75 years) Patients Following Percutaneous Coronary Intervention for Acute Myocardial Infarction-Uncorrected Proof},
journal = {Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology},
year = {2025},
pages = {388--397},
doi = {10.5543/tkda.2025.45606}
}
EUVIMED